Certara Inc at Jefferies London Healthcare Conference Transcript
Thank you for your attendance at our Jefferies London Healthcare Conference. Appreciate your interest here in our health care company guests. I'm Dave Windley with Jefferies Healthcare Equity Research in States and cover drug development supply chain related, I'll call it, the CROs, CDMOs. Certara happens to be a software biosimulation focused player, but selling exclusively in the biopharma R&D and regulatory services area. So here to represent Certara is the company's CEO, William Feehery. Bill, thanks for being here. Really appreciate you being here to talk about Certara.
Questions & Answers
So let me start you off with just talking about the sales dynamics of biosimulation. I think when the company came public in 2020 -- late 2020, was in the throes of the pandemic. We were bringing a COVID vaccine through the pipeline very, very quickly. And people viewed -- it was kind of a new
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |